NovoBiome Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $700K

  • Investors
  • 3

NovoBiome General Information

Description

Developer of a gut-on-chip from human stem cells, limiting animal studies intended to evaluate oral compounds with more reliable and less costly results than animal experiments. The company focuses on the critical nexus of the liver, intestinal diseases like nonalcoholic steatohepatitis, and the gut microbiome with the development of live biotherapeutics, a novel and emerging class of drugs containing living microorganisms, enabling healthcare providers to increase the effectiveness of therapies and the ratio of responding patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 Impasse de la Chapelle
  • 33360 Latresne
  • France
+33 06
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Corporate Office
  • 5 Impasse de la Chapelle
  • 33360 Latresne
  • France
+33 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NovoBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 18-Mar-2026 $700K Completed Startup
2. Early Stage VC (Series A) 18-May-2021 Completed Startup
1. Accelerator/Incubator Completed Startup
To view NovoBiome’s complete valuation and funding history, request access »

NovoBiome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view NovoBiome’s complete cap table history, request access »

NovoBiome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a gut-on-chip from human stem cells, limiting animal studies intended to evaluate oral compounds with more
Other Pharmaceuticals and Biotechnology
Latresne, France
6 As of 2026

Utrecht, Netherlands
 

Ghent, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NovoBiome Competitors (6)

One of NovoBiome’s 6 competitors is HUB Organoids, a Formerly Accelerator/Incubator backed company based in Utrecht, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HUB Organoids Formerly Accelerator/Incubator backed Utrecht, Netherlands
MRM Health Venture Capital-Backed Ghent, Belgium
InSphero Private Equity-Backed Schlieren, Switzerland
Emulate Venture Capital-Backed Boston, MA
TissUse Accelerator/Incubator Backed Berlin, Germany
To view NovoBiome’s complete competitors history, request access »

NovoBiome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NovoBiome Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bernard Magrey Start-Up Win Accelerator/Incubator
Eure Kare VC-Backed Company Minority
Unitec (Accelerator/Incubator) Accelerator/Incubator
To view NovoBiome’s complete investors history, request access »

NovoBiome FAQs

  • When was NovoBiome founded?

    NovoBiome was founded in 2020.

  • Where is NovoBiome headquartered?

    NovoBiome is headquartered in Latresne, France.

  • What is the size of NovoBiome?

    NovoBiome has 6 total employees.

  • What industry is NovoBiome in?

    NovoBiome’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is NovoBiome a private or public company?

    NovoBiome is a Private company.

  • What is NovoBiome’s current revenue?

    The current revenue for NovoBiome is .

  • How much funding has NovoBiome raised over time?

    NovoBiome has raised $2.15M.

  • Who are NovoBiome’s investors?

    Bernard Magrey Start-Up Win, Eure Kare, and Unitec (Accelerator/Incubator) have invested in NovoBiome.

  • Who are NovoBiome’s competitors?

    HUB Organoids, MRM Health, InSphero, Emulate, and TissUse are some of the 6 competitors of NovoBiome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process